vs

Side-by-side financial comparison of Agilent Technologies (A) and eXp World Holdings, Inc. (EXPI). Click either name above to swap in a different company.

Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.2B, roughly 1.5× eXp World Holdings, Inc.). Agilent Technologies runs the higher net margin — 17.0% vs -1.1%, a 18.0% gap on every dollar of revenue. On growth, eXp World Holdings, Inc. posted the faster year-over-year revenue change (8.5% vs 7.0%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $11.9M). Over the past eight quarters, eXp World Holdings, Inc.'s revenue compounded faster (12.4% CAGR vs 6.9%).

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...

eXp World Holdings, Inc. is a global cloud-based real estate services provider. It operates the eXp Realty brokerage network, leverages immersive virtual 3D campus environments to support agent collaboration and operations, serves residential and commercial real estate markets across over 20 countries, and offers complementary services including mortgage, title insurance and professional development resources for real estate practitioners.

A vs EXPI — Head-to-Head

Bigger by revenue
A
A
1.5× larger
A
$1.8B
$1.2B
EXPI
Growing faster (revenue YoY)
EXPI
EXPI
+1.6% gap
EXPI
8.5%
7.0%
A
Higher net margin
A
A
18.0% more per $
A
17.0%
-1.1%
EXPI
More free cash flow
A
A
$163.1M more FCF
A
$175.0M
$11.9M
EXPI
Faster 2-yr revenue CAGR
EXPI
EXPI
Annualised
EXPI
12.4%
6.9%
A

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
A
A
EXPI
EXPI
Revenue
$1.8B
$1.2B
Net Profit
$305.0M
$-12.9M
Gross Margin
52.6%
Operating Margin
19.6%
-1.1%
Net Margin
17.0%
-1.1%
Revenue YoY
7.0%
8.5%
Net Profit YoY
-4.1%
-35.7%
EPS (diluted)
$1.07
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
A
A
EXPI
EXPI
Q1 26
$1.8B
Q4 25
$1.9B
$1.2B
Q3 25
$1.7B
$1.3B
Q2 25
$1.7B
$1.3B
Q1 25
$1.7B
$954.9M
Q4 24
$1.7B
$1.1B
Q3 24
$1.6B
$1.2B
Q2 24
$1.6B
$1.3B
Net Profit
A
A
EXPI
EXPI
Q1 26
$305.0M
Q4 25
$434.0M
$-12.9M
Q3 25
$336.0M
$3.5M
Q2 25
$215.0M
$-2.3M
Q1 25
$318.0M
$-11.0M
Q4 24
$351.0M
$-9.5M
Q3 24
$282.0M
$-8.5M
Q2 24
$308.0M
$12.4M
Gross Margin
A
A
EXPI
EXPI
Q1 26
52.6%
Q4 25
53.2%
Q3 25
51.1%
Q2 25
51.9%
Q1 25
53.5%
Q4 24
53.9%
Q3 24
54.2%
99.9%
Q2 24
54.4%
99.9%
Operating Margin
A
A
EXPI
EXPI
Q1 26
19.6%
Q4 25
23.8%
-1.1%
Q3 25
20.7%
0.3%
Q2 25
18.0%
-0.2%
Q1 25
22.4%
-1.1%
Q4 24
24.0%
-1.0%
Q3 24
21.1%
-0.7%
Q2 24
23.1%
1.4%
Net Margin
A
A
EXPI
EXPI
Q1 26
17.0%
Q4 25
23.3%
-1.1%
Q3 25
19.3%
0.3%
Q2 25
12.9%
-0.2%
Q1 25
18.9%
-1.2%
Q4 24
20.6%
-0.9%
Q3 24
17.9%
-0.7%
Q2 24
19.6%
1.0%
EPS (diluted)
A
A
EXPI
EXPI
Q1 26
$1.07
Q4 25
$1.53
$-0.08
Q3 25
$1.18
$0.02
Q2 25
$0.75
$-0.01
Q1 25
$1.11
$-0.07
Q4 24
$1.23
$-0.06
Q3 24
$0.97
$-0.06
Q2 24
$1.05
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
A
A
EXPI
EXPI
Cash + ST InvestmentsLiquidity on hand
$1.8B
$124.2M
Total DebtLower is stronger
$3.0B
Stockholders' EquityBook value
$6.9B
$242.8M
Total Assets
$12.8B
$442.5M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
A
A
EXPI
EXPI
Q1 26
$1.8B
Q4 25
$1.8B
$124.2M
Q3 25
$1.5B
$112.8M
Q2 25
$1.5B
$94.6M
Q1 25
$1.5B
$115.7M
Q4 24
$1.3B
$113.6M
Q3 24
$1.8B
$130.4M
Q2 24
$1.7B
$108.4M
Total Debt
A
A
EXPI
EXPI
Q1 26
$3.0B
Q4 25
$3.0B
Q3 25
$3.4B
Q2 25
$3.3B
Q1 25
$3.3B
Q4 24
$3.3B
Q3 24
$2.1B
Q2 24
$2.1B
Stockholders' Equity
A
A
EXPI
EXPI
Q1 26
$6.9B
Q4 25
$6.7B
$242.8M
Q3 25
$6.4B
$235.3M
Q2 25
$6.1B
$218.4M
Q1 25
$6.0B
$212.0M
Q4 24
$5.9B
$204.9M
Q3 24
$5.9B
$211.1M
Q2 24
$6.2B
$220.3M
Total Assets
A
A
EXPI
EXPI
Q1 26
$12.8B
Q4 25
$12.7B
$442.5M
Q3 25
$12.2B
$458.7M
Q2 25
$12.2B
$481.2M
Q1 25
$11.9B
$435.8M
Q4 24
$11.8B
$390.7M
Q3 24
$11.0B
$432.6M
Q2 24
$10.9B
$457.4M
Debt / Equity
A
A
EXPI
EXPI
Q1 26
0.44×
Q4 25
0.45×
Q3 25
0.53×
Q2 25
0.55×
Q1 25
0.56×
Q4 24
0.57×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
A
A
EXPI
EXPI
Operating Cash FlowLast quarter
$268.0M
$13.8M
Free Cash FlowOCF − Capex
$175.0M
$11.9M
FCF MarginFCF / Revenue
9.7%
1.0%
Capex IntensityCapex / Revenue
5.2%
0.2%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$993.0M
$109.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
A
A
EXPI
EXPI
Q1 26
$268.0M
Q4 25
$545.0M
$13.8M
Q3 25
$362.0M
$28.9M
Q2 25
$221.0M
$36.1M
Q1 25
$431.0M
$39.8M
Q4 24
$481.0M
$13.7M
Q3 24
$452.0M
$46.0M
Q2 24
$333.0M
$71.1M
Free Cash Flow
A
A
EXPI
EXPI
Q1 26
$175.0M
Q4 25
$452.0M
$11.9M
Q3 25
$259.0M
$26.6M
Q2 25
$107.0M
$33.3M
Q1 25
$334.0M
$37.3M
Q4 24
$388.0M
$11.6M
Q3 24
$360.0M
$44.4M
Q2 24
$230.0M
$69.7M
FCF Margin
A
A
EXPI
EXPI
Q1 26
9.7%
Q4 25
24.3%
1.0%
Q3 25
14.9%
2.0%
Q2 25
6.4%
2.5%
Q1 25
19.9%
3.9%
Q4 24
22.8%
1.1%
Q3 24
22.8%
3.6%
Q2 24
14.6%
5.4%
Capex Intensity
A
A
EXPI
EXPI
Q1 26
5.2%
Q4 25
5.0%
0.2%
Q3 25
5.9%
0.2%
Q2 25
6.8%
0.2%
Q1 25
5.8%
0.3%
Q4 24
5.5%
0.2%
Q3 24
5.8%
0.1%
Q2 24
6.5%
0.1%
Cash Conversion
A
A
EXPI
EXPI
Q1 26
0.88×
Q4 25
1.26×
Q3 25
1.08×
8.26×
Q2 25
1.03×
Q1 25
1.36×
Q4 24
1.37×
Q3 24
1.60×
Q2 24
1.08×
5.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

A
A

Service Other$525.0M29%
Chemicaland Energy Market$422.0M23%
Agilent Cross Lab$273.0M15%
Environmentaland Forensics Market$177.0M10%
Food Market$166.0M9%
Academiaand Government Market$130.0M7%
Applied Markets$98.0M5%

EXPI
EXPI

North American Realty$1.1B96%
International Realty$42.2M4%

Related Comparisons